FGF2 and lymphoproliferative syndrome: Although FGF2 may not always mediate SDC1 expression in cancers, SDC1 overexpression, at either a tissue or serum level, has been reported for multiple tumor types including solid tumors [42-44], lymphomas, and in a number of lymphoproliferative disorders [29,30,45-47].